GMOV: GMO U.S. VALUE ETF
What this ETF is trying to do
The GMO U.S. VALUE ETF (ticker: GMOV) is an exchange-traded fund that holds a variety of different companies. This specific fund contains 165 total holdings. Because the list provided is only a partial view, we can only see some of its largest investments.
What the numbers show
As of September 21, 2026, the current price of one share is $32.56. The estimated price from roughly one year ago was $26.55.
When looking at how much the price changed over the last year, we look at two different numbers:
• One-year price return: This measures only the change in the share price, which was 22.65%.
• One-year total return: This includes both the share price change and any cash distributions paid out. This was 25.27%.
For the current year so far (Year-to-Date), the price return is 18.44%, while the total return is 19.67%. If you had invested $10,000 into the share price alone one year ago, your investment would have grown by approximately 22.65% based on the price change.
Income and distribution explanation
Some investors look for ETFs that pay them cash regularly. These payments are called distributions. This ETF has a distribution yield of 1.81%. In the last 12 months, the fund made four distributions. These payments usually happen every three months (quarterly).
It is important to remember that a "price return" only tracks the movement of the share price. The "total return" is a more complete picture because it includes those cash distributions.
NAV erosion explanation
NAV erosion refers to a decline in the actual value of the assets held within the ETF. For this fund, the erosion-risk score is 100, and the data shows "No price erosion detected." There is no severe erosion-risk flag for this ETF.
Top Holdings
These are some of the largest companies held by the ETF (as of October 4, 2026):
• Microsoft Corp: 7.37%
• Meta Platforms Inc Class A: 5.35%
• ExxonMobil Holdings Corp: 3.52%
• Merck & Co Inc: 3.14%
• Verizon Communications Inc: 2.54%
• JPMorgan Chase & Co: 2.48%
• Pfizer Inc: 2.41%
• Bank of America Corp: 2.15%
• Bristol-Myers Squibb Co: 2.06%
• Johnson & Johnson: 2.01%
Pros
• The ETF has shown positive price returns and total returns over the last year.
• No price erosion was detected by the erosion-risk measurement.
Cons
• The income rating for this ETF is a "C" grade.
• The distribution yield is relatively low at 1.81%.
Beginner takeaway
When looking at an ETF like GMOV, it is helpful to distinguish between the share price and the total return. While the share price tells you how much the cost of one unit has changed, the total return shows you the full picture by including cash payments. Always check if an ETF's goal is to grow in price or to provide regular income.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | MICROSOFT CORP | MSFT | 7.37% |
| 2 | META PLATFORMS INC CLASS A | META | 5.35% |
| 3 | EXXONMOBIL HOLDINGS CORP | XOM | 3.52% |
| 4 | MERCK & CO INC | MRK | 3.14% |
| 5 | VERIZON COMMUNICATIONS INC | VZ | 2.54% |
| 6 | JPMORGAN CHASE & CO | JPM | 2.48% |
| 7 | PFIZER INC | PFE | 2.41% |
| 8 | BANK OF AMERICA CORP | BAC | 2.15% |
| 9 | BRISTOL-MYERS SQUIBB CO | BMY | 2.06% |
| 10 | JOHNSON & JOHNSON | JNJ | 2.01% |